Shenzhen New Industries Biomedical Engineering Co., Ltd. (SHE: 300832)

Shenzhen New Industries Biomedical Engineering Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Operating Revenue	4,426	3,920	3,040	2,539	2,190	1,680
Other Revenue	9.91	9.91	6.47	6.17	5.12	1.59
Revenue	4,436	3,930	3,047	2,545	2,195	1,682
Revenue Growth (YoY)	21.25%	28.97%	19.70%	15.97%	30.53%	21.54%
Cost of Revenue	1,204	1,062	906.2	734.3	500.87	337
Gross Profit	3,232	2,867	2,141	1,811	1,694	1,345
Selling, General & Admin	775.7	737.27	463.67	537.29	503.63	378.64
Research & Development	422.18	366.05	317.71	215.05	150.58	118.85
Other Operating Expenses	45.4	15.25	12.49	8.57	5.72	3.56
Operating Expenses	1,262	1,129	807.89	753.54	671.47	515.08
Operating Income	1,970	1,739	1,333	1,058	1,023	829.51
Interest Expense	-0.4	-0.43	-0.27	-0.15	-	-
Interest & Investment Income	102.7	89.8	66.76	56.6	59.74	41.87
Currency Exchange Gain (Loss)	17.71	17.71	68.98	-31.3	-27.1	7.52
Other Non Operating Income (Expenses)	-8.98	-2.83	-2.23	-1.43	2.5	-3.79
EBT Excluding Unusual Items	2,081	1,843	1,466	1,081	1,058	875.11
Gain (Loss) on Sale of Investments	4.6	18.55	15.62	18.76	0.97	-
Gain (Loss) on Sale of Assets	-0.25	0.05	0.62	0.1	-0.25	0
Asset Writedown	-1.52	-1.52	-1.52	-1.86	-0.63	-0.13
Other Unusual Items	27.96	33.23	20.38	37.24	38.89	23.48
Pretax Income	2,111	1,893	1,501	1,136	1,097	898.47
Income Tax Expense	260.89	239.41	173.28	161.83	157.61	125.86
Net Income	1,851	1,654	1,328	973.7	939.15	772.61
Net Income to Common	1,851	1,654	1,328	973.7	939.15	772.61
Net Income Growth	16.38%	24.53%	36.38%	3.68%	21.56%	11.33%
Shares Outstanding (Basic)	786	785	785	784	750	704
Shares Outstanding (Diluted)	786	786	786	786	750	704
Shares Change (YoY)	-0.01%	-0.06%	0.05%	4.76%	6.61%	-0.00%
EPS (Basic)	2.36	2.11	1.69	1.24	1.25	1.10
EPS (Diluted)	2.36	2.10	1.69	1.24	1.25	1.10
EPS Growth	16.40%	24.61%	36.32%	-1.03%	14.02%	11.33%
Free Cash Flow	1,064	1,096	559.17	430.28	721.84	504.62
Free Cash Flow Per Share	1.35	1.39	0.71	0.55	0.96	0.72
Dividend Per Share	1.000	1.000	0.700	0.600	1.316	-
Dividend Growth	42.86%	42.86%	16.67%	-54.40%	-	-
Gross Margin	72.86%	72.96%	70.26%	71.15%	77.18%	79.96%
Operating Margin	44.40%	44.24%	43.74%	41.55%	46.59%	49.33%
Profit Margin	41.72%	42.08%	43.58%	38.25%	42.79%	45.95%
Free Cash Flow Margin	23.98%	27.89%	18.35%	16.90%	32.89%	30.01%
EBITDA	2,143	1,886	1,445	1,151	1,102	882.47
EBITDA Margin	48.31%	47.98%	47.42%	45.23%	50.20%	52.48%
D&A For EBITDA	173.54	147.11	111.87	93.64	79.15	52.96
EBIT	1,970	1,739	1,333	1,058	1,023	829.51
EBIT Margin	44.40%	44.24%	43.74%	41.55%	46.59%	49.33%
Effective Tax Rate	12.36%	12.65%	11.54%	14.25%	14.37%	14.01%
Revenue as Reported	4,436	3,930	3,047	2,545	2,195	1,682
Advertising Expenses	-	58.54	34.34	20.25	2.31	2.38

Source: S&P Capital IQ. Standard template. Financial Sources.